MACROGENICS, INC. Increase (Decrease) in Inventories
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Inventories of $1.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-08-14
- MACROGENICS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$347.00K.
- MACROGENICS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $1.59M, a 83.14% decline year-over-year.
- MACROGENICS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was -$840.00K, a 609.09% decline year-over-year.
- MACROGENICS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was -$525.00K, a 124.66% decline year-over-year.
- MACROGENICS, INC. increase (decrease) in inventories for fiscal 2025 was $7.91M, a 261.52% increase from fiscal 2024.
- MACROGENICS, INC. increase (decrease) in inventories for fiscal 2024 was $2.19M.
- MACROGENICS, INC. increase (decrease) in inventories for fiscal 2023 was -$230.00K.
- MACROGENICS, INC. increase (decrease) in inventories for fiscal 2022 was -$55.00K, a 100.86% decline from fiscal 2021.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$347.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.24M 10-Q · filed 2026-08-14 | $402.00K derived: sum of 3 quarters · filed 2026-08-14 | -$123.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $1.59M 10-Q · filed 2026-05-13 | $749.00K derived: sum of 2 quarters · filed 2026-05-13 | $224.00K derived: sum of 3 quarters · filed 2026-05-13 | $73.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | -$840.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$1.36M derived: sum of 2 quarters · filed 2026-03-09 | -$1.52M derived: sum of 3 quarters · filed 2026-08-14 | $7.91M 10-K · filed 2026-03-09 |
| 2025-09-30 | -$525.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$676.00K derived: sum of 2 quarters · filed 2026-08-14 | $8.75M 10-Q · filed 2025-11-12 | $8.91M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$151.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $9.28M 10-Q · filed 2026-08-14 | $9.44M derived: sum of 3 quarters · filed 2026-08-14 | $11.57M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $9.43M 10-Q · filed 2026-05-13 | $9.59M derived: sum of 2 quarters · filed 2026-05-13 | $11.72M derived: sum of 3 quarters · filed 2026-05-13 | $11.59M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $165.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $2.29M derived: sum of 2 quarters · filed 2026-03-09 | $2.16M derived: sum of 3 quarters · filed 2026-03-09 | $2.19M 10-K · filed 2026-03-09 |
| 2024-09-30 | $2.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.00M derived: sum of 2 quarters · filed 2025-11-12 | $2.02M 10-Q · filed 2025-11-12 | $2.18M derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-06-30 | -$133.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$106.00K 10-Q · filed 2025-08-14 | $49.00K derived: sum of 3 quarters · filed 2026-03-09 | -$328.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2024-03-31 | $27.00K 10-Q · filed 2025-05-13 | $182.00K derived: sum of 2 quarters · filed 2026-03-09 | -$195.00K derived: sum of 3 quarters · filed 2026-03-09 | -$161.00K derived: sum of 4 quarters · filed 2026-03-09 |
| 2023-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | -$222.00K derived: sum of 2 quarters · filed 2026-03-09 | -$188.00K derived: sum of 3 quarters · filed 2026-03-09 | -$230.00K 10-K · filed 2026-03-09 |
| 2023-09-30 | -$377.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | -$343.00K derived: sum of 2 quarters · filed 2024-11-05 | -$385.00K 10-Q · filed 2024-11-05 | -$21.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-06-30 | $34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$8.00K 10-Q · filed 2024-08-06 | $356.00K derived: sum of 3 quarters · filed 2025-03-20 | $299.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2023-03-31 | -$42.00K 10-Q · filed 2024-05-09 | $322.00K derived: sum of 2 quarters · filed 2025-03-20 | $265.00K derived: sum of 3 quarters · filed 2025-03-20 | -$307.00K derived: sum of 4 quarters · filed 2025-03-20 |
| 2022-12-31 | $364.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $307.00K derived: sum of 2 quarters · filed 2025-03-20 | -$265.00K derived: sum of 3 quarters · filed 2025-03-20 | -$55.00K 10-K · filed 2025-03-20 |
| 2022-09-30 | -$57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | -$629.00K derived: sum of 2 quarters · filed 2023-11-06 | -$419.00K 10-Q · filed 2023-11-06 | $423.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-06-30 | -$572.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$362.00K 10-Q · filed 2023-08-09 | $480.00K derived: sum of 3 quarters · filed 2024-03-07 | -$414.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2022-03-31 | $210.00K 10-Q · filed 2023-05-09 | $1.05M derived: sum of 2 quarters · filed 2024-03-07 | $158.00K derived: sum of 3 quarters · filed 2024-03-07 | $462.00K derived: sum of 4 quarters · filed 2024-03-07 |
| 2021-12-31 | $842.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | -$52.00K derived: sum of 2 quarters · filed 2024-03-07 | $252.00K derived: sum of 3 quarters · filed 2024-03-07 | $6.42M 10-K · filed 2024-03-07 |
| 2021-09-30 | -$894.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$590.00K derived: sum of 2 quarters · filed 2022-11-03 | $5.58M 10-Q · filed 2022-11-03 | $5.58M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-06-30 | $304.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $6.48M 10-Q · filed 2022-08-08 | $6.48M derived: sum of 3 quarters · filed 2023-03-15 | $6.48M derived: sum of 4 quarters · filed 2023-03-15 |
| 2021-03-31 | $6.17M 10-Q · filed 2022-05-03 | $6.17M derived: sum of 2 quarters · filed 2023-03-15 | $6.17M derived: sum of 3 quarters · filed 2023-03-15 | $6.17M derived: sum of 4 quarters · filed 2023-03-15 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $0.00 derived: sum of 2 quarters · filed 2023-03-15 | $0.00 derived: sum of 3 quarters · filed 2023-03-15 | $0.00 10-K · filed 2023-03-15 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $0.00 derived: sum of 2 quarters · filed 2021-11-02 | $0.00 10-Q · filed 2021-11-02 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $0.00 10-Q · filed 2021-07-29 | ||
| 2020-03-31 | $0.00 10-Q · filed 2021-04-29 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |